The 2017 Cell Mapping Symposium, hosted by Nevan Krogan of the Quantitative Biosciences Institute (QBI) at UCSF, Trey Ideker of the Cancer Cell Map Initiative (CCMI) at UC San Diego and Jeremy Willsey of the Psychiatric Cell Map Initiative (PCMI) at UCSF, will address research and technology advances in cell mapping as it relates to cancer, psychiatric disorders and infectious diseases.

The ability of a cell to respond to its environment depends on the actions of the proteins encoded by the DNA in the genome. However, most proteins don’t work alone. They work with other proteins in teams called complexes. The principles of “cell mapping” are to figure out which proteins work together in complexes. Mapping can be done in different disease states or in the presence of different chemical drugs. To accomplish these goals, researchers augment these cell maps with genetic maps to derive quantitative insights into how biological functions of cells can be restored.

One of the main objectives of this symposium is to discuss technological advances in extracting mechanistic insight from these large genome sequencing projects. These efforts include using proteomic, biochemical, genetic and structural biology approaches to generate cellular maps that can be used to interpret this genomic data from a variety of different disease areas. 

The 2017 Cell Mapping Symposium, will be held over 2 days, September 13 and September 14, 2017, at Gladstone Institutes in San Francisco’s Mission Bay neighborhood. The symposium will start at 1:00 pm on September 13th, at the Mahley Auditorium and end at 4:30 pm on September 14th. 

The complete schedule can be found here.